Meta Platforms
META
Coinbase
COIN
MARA Holdings
MARA
Petroleo Brasileiro SA Petrobras
PBR
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
OMER Omeros
- 10.000
- 0.0000.00%
Close Dec 24 13:00 ET
- 9.980
- -0.020-0.20%
Pre 09:28 ET
579.50MMarket Cap-4.35P/E (TTM)
0.000High0.000Low0Volume0.000Open10.000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)57.95MShares13.60052wk High-3.76P/B553.74MFloat Cap2.61252wk Low--Dividend TTM55.37MShs Float30.230Historical High--Div YieldTTM0.00%Amplitude0.920Historical Low--Avg Price1Lot Size
About Omeros Company
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Company Profile
SymbolOMER
Company NameOmeros
Listing DateOct 8, 2009
Issue Price10.00
Founded1994
CEODr. Gregory A. Demopulos,M.D.
MarketNASDAQ
Employees198
Fiscal Year Ends12-31
AddressThe Omeros Building,201 Elliott Avenue West
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98119
Phone1-206-676-5000
Websitehttp://www.omeros.com
Company Executives
- Name
- Position
- Salary
- Dr. Gregory A. Demopulos,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 7.69M
- Nadia Dac
- Vice President and Chief Commercial Officer
- --
- Dr. George A. Gaitanaris, M.D.,PhD
- Vice President, Science and Chief Scientific Officer
- --
- Dr. Andreas Grauer, M.D.
- Vice President and Chief Medical Officer
- --
- Dr. Catherine A. Melfi, PhD
- Vice President, Regulatory Affairs and Quality Systems and Chief Regulatory Officer
- --
- David J. Borges
- Vice President, Finance, Chief Accounting Officer, Principal Financial Officer and Treasurer
- --
- Dr. Mariana N. Dimitrova
- Vice President, Chemistry, Manufacturing and Controls
- --
- Dr. J. Whitaker, J.D.,M.D.
- Vice President, Clinical Development
- --
- Peter W. Williams
- Vice President, Human Resources
- --
- Peter B. Cancelmo
- Vice President, General Counsel and Corporate Secretary
- 852.63K
- Diana T. Perkinson
- Director
- 174.66K
- Dr. Peter A. Demopulos,M.D.
- Director
- 122.60K
- Dr. Thomas F. Bumol, PhD
- Independent Director
- 127.60K
- Thomas J. Cable
- Lead Independent Director
- 177.60K
- Arnold C. Hanish
- Independent Director
- 137.60K
- Dr. Leroy E. Hood,M.D.,Ph.
- Independent Director
- 135.10K
- Dr. Rajiv Shah, M.D.
- Independent Director
- 140.10K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.